Value creation starts with a simple equation:
Our portfolio includes investments across all emerging disciplines, such as autonomous systems/AI, quantum technology, mobility, sustainable energy, genomics, synthetic biology, life sciences, and blockchain. This leads to a diversified portfolio of companies with category-creating potential.

3Laws Robotics
Professor Aaron Ames
Acquired by Amazon (NASDAQ: AMZN)
Autonomous and robotic systems that do no harm.

Asymptote Bio
Professor Michael Elowitz
Next generation precision CNS therapeutrics.
Currently in stealth

Demeter
Professor Magda Zernicka-Goetz and Changhuei Yang
Revolutionizing IVF with AI imaging.

Endogenous Therapeutics
Professor Stephen Mayo
In vivo nanoparticles for autoimmune disease.

Flion
Professor Kimberly See
Sustainable energy storage from abundant eco-materials.
Currently in stealth

HEPT
Professor Ali Hajimiri
Hybrid electronic, photonic technology.
Currently in stealth

KAIperShield
Daniel Crichton, Kymie Tan & Lt. Gen (Ret.) Larry James
Mission-critical cyber resilience for complex cyber-physical systems.

Oratomic
Dolev Bluvstein & Professor Manuel Endres
Fault-tolerant, utility-scale quantum computers built from neutral atoms.

Palamedrix
Acquired by Somalogic (NASDAQ: SLGC)
Intra-cellular interrogation at analyte resolution.

Receptive Bio
Professor Viviana Gradinaru
Neuroscience target discovery.
Currently in stealth

Soaring Technologies
Professor Mory Gharib
Drone technology for advanced military and logistics. American Made.

Switch Therapeutics
Professor Bill Goddard
Next-generation RNAi therapies for unmet diseases.

Taliesin Rx
CalTech PhD, Phillip Patten
Our mission is to discover and development a new class of cardiac-selective drugs.

Tera AI
Caltech PhD, Tony Zhang
The first unified spatial AI stack for mapping and
navigation, cross-platform, gps-denied.